Kymera Therapeutics Inc.
KYMR | NASDAQ
$117.67
-$0.08 (-0.07%)
At close: Sep 21, 2026, 4:00 PM ET
$117.67
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $9.69B
Enterprise Value $9.07B
Beta 1.97
Average Volume 759.43K
Shares Outstanding (Diluted) 98.18M
Shares Change YoY 22.04%
Institutional Ownership 98.73%
Exchange NASDAQ
ISIN US5015751044
Price Performance
Price Change 1M -1.7%
Price Change 3M 19.8%
Price Change 6M 49.1%
Price Change YTD 61.7%
Price Change 1Y 130.7%
Price Change 3Y 572.4%
Price Change 5Y 88.3%
1M CAGR (ann.) 10.7%
1Y CAGR (ann.) 144.7%
5Y CAGR (ann.) 12.1%
All-Time CAGR 23.1%
Valuation
PE Ratio -36.21
Forward PE N/A
PEG Ratio -6.52
Forward PEG -1.19
PS Ratio 92.19
Forward PS 240.80
PB Ratio 6.41
P/FCF Ratio -40.68
P/Adj. FCF Ratio -31.93
P/OCF Ratio -48.83
EV/Sales 86.39
EV/EBIT -30.27
EV/EBITDA -30.98
EV/FCF -38.12
Earnings Yield -2.8%
FCF Yield -2.5%
Adj. FCF Yield -3.1%
Financial Health
Net Cash $690.99M
Total Debt $82.22M
Cash & Short-Term Investments $690.99M
Total Assets $1.65B
Current Ratio 9.83
Quick Ratio 9.91
Debt / Equity Ratio 0.05
Debt / EBITDA -0.28
Debt / FCF -0.35
OCF / Debt -2.88
Interest Coverage -1,659.61
Altman Z-Score 40.48
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 102.0%
Operating Profit Margin -333.5%
EBITDA Margin -278.9%
Net Profit Margin -285.4%
FCF Margin -226.7%
Adj. FCF Margin -288.8%
SBC / Revenue 62.1%
SBC Impact (per share) -27.4%
Returns
Return on Assets -18.2%
Return on Equity -21.5%
Return on Invested Capital -22.1%
Return on Capital Employed -22.3%
Return on Tangible Assets -18.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 26.7%
Revenue CAGR 5Y 10.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -13.6%
EPS CAGR 5Y -6.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -23.9%
FCF CAGR 5Y -12.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 27
EPS Growth Next 3Y -25.4%
Revenue Growth Next 3Y -14.3%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$1.25
EPS Growth Est (next Q) 38.9%
Revenue Est (next Q) $3.28M
Revenue Growth Est (next Q) 18.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $136.75
Price Target Upside 16.2%
Cash Flow
Operating Cash Flow $-236.76M
Free Cash Flow $-237.96M
Adj. Free Cash Flow $-303.16M
FCF Per Share -$2.42
OCF Per Share -$2.41
OCF/S Ratio -225.5%
Income Statement
Revenue $104.99M
Gross Profit $107.07M
Operating Income $-350.18M
EBITDA $-292.76M
Net Income $-299.65M
EPS (Diluted) -$3.25
Revenue / Employee $384.58K
Profit / Employee $-1.1M
Employees 273
Add to Watchlist
Select watchlists to add or remove KYMR